David S. Kinard - Mar 3, 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President, Human Resources, Corporate Affairs and Administration
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for David S. Kinard
Stock symbol
ELAN
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/5/2025, 06:47 PM
Previous filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +22.1K +13.25% $0.00 189K Mar 3, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option (right to buy) Award $0 +46.4K $0.00 46.4K Mar 3, 2025 Common Stock 46.4K $11.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028.
F2 Grant of stock options vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028.

Remarks:

Executive Vice President, Human Resources, Corporate Affairs and Administration